Literature DB >> 21133848

Computational polypharmacology with text mining and ontologies.

Conrad Plake1, Michael Schroeder.   

Abstract

Huge volumes of data, produced by microarrays and next- generation sequencing, are now at the fingertips of scientists and allow to expand the scope beyond conventional drug de- sign. New promiscuous drugs directed at multiple targets promise increased therapeutic efficacy for treatment of multi- factorial diseases. At the same time, more systematic tests for unwanted side effects are now possible. In this paper, we focus on the application of text mining and ontologies to support experimental drug discovery. Text mining is a high- throughput technique to extract information from millions of scientific documents and web pages. By exploiting the vast number of extracted facts as well as the indirect links between them, text mining and ontologies help to generate new hypotheses on drug target interactions. We review latest applications of text mining and ontologies suitable for target and drug-target interaction discovery in addition to conventional approaches. We conclude that mining the literature on drugs and proteins offers unique opportunities to support the laborious and expensive process of drug development.

Mesh:

Substances:

Year:  2011        PMID: 21133848     DOI: 10.2174/138920111794480624

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  8 in total

Review 1.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Mining the pharmacogenomics literature--a survey of the state of the art.

Authors:  Udo Hahn; K Bretonnel Cohen; Yael Garten; Nigam H Shah
Journal:  Brief Bioinform       Date:  2012-07       Impact factor: 11.622

3.  Discovery and explanation of drug-drug interactions via text mining.

Authors:  Bethany Percha; Yael Garten; Russ B Altman
Journal:  Pac Symp Biocomput       Date:  2012

4.  eMatchSite: sequence order-independent structure alignments of ligand binding pockets in protein models.

Authors:  Michal Brylinski
Journal:  PLoS Comput Biol       Date:  2014-09-18       Impact factor: 4.475

5.  iDTI-ESBoost: Identification of Drug Target Interaction Using Evolutionary and Structural Features with Boosting.

Authors:  Farshid Rayhan; Sajid Ahmed; Swakkhar Shatabda; Dewan Md Farid; Zaynab Mousavian; Abdollah Dehzangi; M Sohel Rahman
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

6.  Compensating for literature annotation bias when predicting novel drug-disease relationships through Medical Subject Heading Over-representation Profile (MeSHOP) similarity.

Authors:  Warren A Cheung; B F Francis Ouellette; Wyeth W Wasserman
Journal:  BMC Med Genomics       Date:  2013-05-07       Impact factor: 3.063

7.  Identification of new biomarker candidates for glucocorticoid induced insulin resistance using literature mining.

Authors:  Wilco Wm Fleuren; Erik Jm Toonen; Stefan Verhoeven; Raoul Frijters; Tim Hulsen; Ton Rullmann; René van Schaik; Jacob de Vlieg; Wynand Alkema
Journal:  BioData Min       Date:  2013-02-04       Impact factor: 2.522

8.  Cardiovascular Disease Chemogenomics Knowledgebase-guided Target Identification and Drug Synergy Mechanism Study of an Herbal Formula.

Authors:  Hai Zhang; Shifan Ma; Zhiwei Feng; Dongyao Wang; Chengjian Li; Yan Cao; Xiaofei Chen; Aijun Liu; Zhenyu Zhu; Junping Zhang; Guoqing Zhang; Yifeng Chai; Lirong Wang; Xiang-Qun Xie
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.